A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
Eli Lilly and Company
Pfizer
Alterome Therapeutics, Inc.
Xencor, Inc.
City of Hope Medical Center
Pfizer
University Hospital, Clermont-Ferrand
University of Pennsylvania
Duke University
A2 Biotherapeutics Inc.
Mirati Therapeutics Inc.
Arvinas Inc.
Zhejiang University
National Institutes of Health Clinical Center (CC)
ALX Oncology Inc.
Ulsan University Hospital
University of Colorado, Denver
Roswell Park Cancer Institute
Pheon Therapeutics
Pheon Therapeutics
City of Hope Medical Center
Seagen Inc.
Orano Med LLC
Eli Lilly and Company
Novartis
Var2 Pharmaceuticals
University of Salamanca
Takeda
NantCell, Inc.
City of Hope Medical Center
AstraZeneca
Revolution Medicines, Inc.
University of Pittsburgh
Tempus AI
Eli Lilly and Company
Virginia Commonwealth University
University of Calgary
HUYABIO International, LLC.
HUYABIO International, LLC.
Stony Brook University
A2 Biotherapeutics Inc.
Centre Hospitalier de Valence
Elicio Therapeutics
Revolution Medicines, Inc.
GONGCHU Biotechnology Co., Ltd
Palleon Pharmaceuticals, Inc.
Jonsson Comprehensive Cancer Center
Novita Pharmaceuticals, Inc.
Turning Point Therapeutics, Inc.